Kathy Salmonson
Datos Biográficos
| ID | 10011882 |
|---|---|
| NOMBRE | Kathy Salmonson |
| NOMBRES | Kathy |
| APELLIDO | Salmonson |
| FIRMA | SALMONSON K |
| AFILIACIONES | Harmonic Drive (Germany) |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2026 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience
Introduction: Psilocybin therapy has demonstrated efficacy for cancer-related anxiety and depression, but resource-intensive individual treatment models raise important questions for psychedelic public health about equitable access and scalability. In our prior Phase 1/2 study of group retreat psilocybin therapy for patients with metastatic cancer, we observed partial responders who did not achieve full therapeutic benefit. No published research …
Sin obras prominentes en esta página.
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience
Introduction: Psilocybin therapy has demonstrated efficacy for cancer-related anxiety and depression, but resource-intensive individual treatment models raise important questions for psychedelic public health about equitable access and scalability. In our prior Phase 1/2 study of group retreat psilocybin therapy for patients with metastatic cancer, we observed partial responders who did not achieve full therapeutic benefit. No published research …
Adverse effect (1 obras) · Antidepressant (1 obras) · Anxiety (1 obras) · Dosing (1 obras) · Forensic Toxicology and Drug Analysis (1 obras) · Hallucinogen (1 obras) · Nausea (1 obras) · Pain Management and Placebo Effect (1 obras) · Psilocybin (1 obras) · Psychedelics and Drug Studies (1 obras)